Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CONJUGATE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/138682
Kind Code:
A1
Abstract:
The present invention relates to a compound of formula (I), or a tautomer, stereoisomer, pharmaceutically acceptable salt or isotopic variant thereof. The compound represented by formula (I) or the tautomer, stereoisomer, pharmaceutically acceptable salt or isotopic variant thereof is used as a novel linker compound, and can be used for preparing an ADC drug having a high DAR value. The present invention also relates to an ADC drug prepared by the linker.

Inventors:
CHEN JIAN (CN)
ZHAO HAIBO (CN)
Application Number:
PCT/CN2023/073332
Publication Date:
July 27, 2023
Filing Date:
January 20, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BEIJING CHEMPION BIOTECHNOLOGY CO LTD (CN)
International Classes:
C07C237/08; A61K47/60; A61K47/66; A61K47/68; A61P35/00
Domestic Patent References:
WO2022161452A12022-08-04
WO2021257917A12021-12-23
WO2021072246A12021-04-15
WO2022015656A12022-01-20
Foreign References:
CN110234357A2019-09-13
EP2913064A12015-09-02
CN101541332A2009-09-23
CN109206610A2019-01-15
CN110835316A2020-02-25
DE10326303A12004-12-30
US20130052130A12013-02-28
US20170239364A12017-08-24
Other References:
GIESE MATTHEW, DAVIS PAUL D., WOODMAN ROBERT H., HERMANSON GREG, POKORA ALEX, VERMILLION MELISSA: "Linker Architectures as Steric Auxiliaries for Altering Enzyme-Mediated Payload Release from Bioconjugates", BIOCONJUGATE CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 32, no. 10, 20 October 2021 (2021-10-20), US , pages 2257 - 2267, XP093079996, ISSN: 1043-1802, DOI: 10.1021/acs.bioconjchem.1c00429
Attorney, Agent or Firm:
LIU, SHEN & ASSOCIATES (CN)
Download PDF: